In recent years, digital health solutions have been developed for a variety of chronic conditions, but have yet to meet their promise. This “translation gap” represents a target for improving the state of digital health and bettering the health outcomes of patients. Mental healthcare, in particular, […]
Meeting Patients’ Needs – the Role of the Provider
Taking on a more holistic approach to care requires consideration of a patient’s social determinants of health (SDoH). Amongst these factors is whether the patient’s basic needs are being met. A recent survey of 75 provider systems found that most providers are considering SDoH, but these efforts […]
New MDCG Guidance on Conformity Assessment and Notified Bodies
The Medical Device Coordination Group (MDCG) has released a new guidance pertaining to conformity assessment and notified bodies. In part 1 of the guidance, the MDCG seeks to support the process of designating notified bodies in NANDO. In the second part, the guidance goes over the notification […]
Inflation is Impacting Healthcare Decisions of Nearly 40% of Americans
The rising cost of healthcare has been exacerbated by inflation, impacting the healthcare decisions of almost 40% of US residents. A newly published West Health/Gallup shows healthcare cost increases have caused a large swath of the population to delay or miss healthcare, cut expenses, and incur […]
Connecting Mental Healthcare with Primary Care to Improve Health Outcomes
Millions of people in the US who would benefit from mental healthcare are unable to do so due to a litany of barriers to access. Integrating primary care and mental healthcare could help lower barriers and get care to more patients. However, it will take a multipronged strategy from all stakeholders […]
Crest Digital Health Targets Bipolar Disorder with Digital Health Solution
Patients with bipolar disorder often face poor health outcomes, especially when treatment plans are followed inconsistently or discontinued. Crest Digital Therapeutics, founded by Stephen Hamm, seeks to improve outcomes for people with bipolar disorder with its software platform that helps keep […]
Endo Will File for Bankruptcy Due to Opioid Lawsuits “Imminently”
Endo International signaled on Tuesday, August 11th, that bankruptcy is in the company’s immediate future. The announcement comes as the company faces thousands of lawsuits related to its role in the US opioid epidemic. The suits center around its drug Opana ER, which was pulled from […]
Pharma Voice Woman of the Week: Miruna Sasu, President and CEO of COTA
On this week’s episode of the Woman of the Week by PharmaVoice podcast, host Taren Grom sits down with the CEO and president of COTA, Miruna Sasu. In the interview, Sasu talked about the power of real-world data (RWD) and real-world evidence (RWD) in driving future advances in oncology. When […]
Essential Terms for UK Quality Regulations Post-Brexit
Many biotechs are struggling with the uncertain state of quality regulations in the Post-Brexit UK. Understanding the new regulatory processes and requirements begins with understanding the key terms in a new MasterControl article, Joanna Blair breaks down the top 11 terms you need to know to […]
Pharma Preps Legal Strategy Against New US Drug Pricing Regulation
The US Senate’s newly passed drug pricing regulation will allow Medicare to cut the prices of a select number of drugs over the course of the decade. In response, pharma companies have begun prepping their legal objections to the rule. The industry will likely sue the Center for Medicare and […]
Webinar: Confronting Care Inequities in Hospital Medicine
Although awareness of health disparities among marginalized racial and ethnic groups has grown in recent years, simply understanding the problem does not fix it. In a new webinar hosted by Becker’s Hospital Review, Greg Johnson, MD, SFHM, CEO of hospital medicine and chief diversity officer at Sound […]
Pharma Marketing USA 2022 Article: Pharma Needs a Digital Reset Same as Above
Reaching the most important stakeholders in pharma, patients and their HCPs, requires breaking down operational silos and creating cross-functional teams. Doing so can help companies condense the science to actionable content that’s tailored for their audience. Building such teams starts with […]
Exploring the Process for the Inflation Reduction Act Drug Price Negotiations
The Democrats’ Inflation Reduction Act includes a provision to let the US government negotiate the prices of certain medications for Medicare recipients. If passed, Medicare would be able to negotiate the price of 10 drugs in 2026 and another 20 by 2030. The slate of drugs targetted would include […]
How Real-World Data Can Help Expedite Approval for Diseases with Few Treatments
For patients with currently untreatable diseases, new treatment options represent a glimmer of hope. However, the classic drug approval process is slow and can delay new therapies from reaching patients before it is too late. In a new Stat News article, Elenee Argentinis explains how real-world data […]
High Tolerance for Medical Errors in Hospital Settings
Despite efforts like the Hospital-Acquired Conditions Reduction Program, the rate of hospital-acquired conditions in US hospitals is still startlingly high. In a new interview, Becker’s Hospital Review spoke with Patricia McGaffin, RN, VP of safety programs at the Institute for Healthcare […]
J&J Head of R&D Steps Down Unexpectedly
Mathai Mammen, MD, PhD, has stepped down from his role as head of research and development at Johnson & Johnson. Mammen, who joined the company in 2017, was appointed VP of pharmaceuticals R&D just last year. According to an announcement made yesterday, August 8th, his departure is based on […]
US Government Eyes Transdermal Vaccinations for Monkeypox
As cases of monkeypox rise in the US, unnamed sources are indicating the government will push for transdermal injection for Jyneos, the monkeypox vaccine produced by Bavarian Nordic. The scale of the outbreak, which resulted in a declaration of a national health emergency just last week, combined […]
UK Lord’s Committee Share Worries Over Nation’s Goal to Become ‘Science Superpower”
The UK Lord’s Committee has released a report that casts doubts over the UK government’s goal of ‘science and technology superpower’. Last year, the government released its 2021 Integrated Review of Security, Defence, Development and Foreign Policy report that solidified these ambitions. The […]
Value in Health: Defining a Core Data Set for the Economic Evaluation of Precision Oncology
Despite the growing abundance of multiomic data in precision oncology, the lack of standardization and interoperability impedes economic evaluation. In the latest issue of Value in Health, Samantha Pollard, PhD et al. found significant variability in published data resources. Through their work, […]
Evidence Partners® Inc. Secures $20 Million in Growth Financing
Evidence Partners® Inc. announced today, August 9th, that it has closed a growth financing round worth $20 million. The funding comes from Thomwest Ventures, Pender Ventures, and Export Development Canada. Evidence Partners is known as a leader in artificial intelligence (AI)-based automated […]
Whitepaper – Adaptive Trial Designs in Early Oncology: Minimizing Risk & Accelerating Timelinesv
Despite a growing understanding of cancer biology, only 10% of cancer treatments approved by the FDA have an overall survival benefit for patients. A newly available white paper lays out the current precision medicine landscape and how the shift towards adaptive trial designs could accelerate market […]
Inflation Reduction Act Maintains Expanded Health Insurance Subsidies
The Inflation Reduction Act, passed by the US Senate this Sunday, would preserve healthcare subsidies for 13 million people who purchase care through the marketplace. The bill, if passed by the House, would extend the subsidies through 2025. Originally, the subsidies only extended to the end of […]
NPR Poll: One in Five US Residents with Serious Illness Couldn’t Access Care During COVID-19 Pandemic
A newly released survey from NPR shows that the COVID-19 pandemic severely impacted access to care for approximately 20% of people from US households where one or more residents has a serious illness. The poll, performed in collaboration with the Harvard T.H. Chan School of Public Health and the […]
US FDA Gives Quick Approval for First Low-HER2 Breast Cancer Drug
The US Food and Drug Administration (FDA) has approved Enhurtu, the first drug to treat metastatic or unresectable low-HER2 breast cancer, a recently defined category of the disease. The drug, developed by AstraZeneca and Daiichi Sankyo, received expedited approval from the agency, in part because […]
US Senate Passes Democrat’s Flagship Climate, Drug Pricing, and Tax Bill
After months of negotiations and setbacks, Democrats in the US Senate have passed a pared-down version of their tax, climate, and drug pricing reform bill. Included in the bill is a provision that would limit the price of Insulin to $35 a month for Medicare recipients. Previous iterations of the […]
Focus on femtech: New journey towards women’s health
It took five years, four medical examinations and several painful scans for Mumbai-based Yogita Singh (name changed on request) to undertake the road to recovery after being detected with breast cancer. Singh was 49 when she first started experiencing severe headaches followed by fatigue. Initially, […]
NLP in Healthcare and Life Sciences Market Projected to Gain $4.3 Billion by 2026
Report classifies the NLP in Healthcare and Life Sciences Market based on components, deployment mode, organization size, NLP type, application, end user, and regions. Northbrook, IL 60062 -- (SBWIRE) -- 07/15/2022 -- According to a research report "NLP in Healthcare and Life Sciences Market by […]
California’s low-cost insulin plans receive $100m manufacturing boost
Insulin prices made the headlines again as California governor Gavin Newsom announced plans on 7 July for the state to manufacture low-cost insulin. In a budget change proposed in February and confirmed in May , California’s Department of Health Care Access and Information (HCAI) requested a […]
Illumina strikes $325M deal to end years-long patent battles
After spending the last 10-plus years in court, Illumina and BGI Group have reached a $325 million settlement to resolve a number of patent and antitrust claims across the US centered around the companies’ DNA sequencing technology. Read the source article at […]
Pandemic Windfall Upends Status Quo For Top-10 Best-Selling Drugs
Now that the books for 2021 are closed, In Vivo has crunched the numbers and can report on the best-selling pharmaceuticals last year. And what a year it was, with expectations for drug launches having been completely rewritten. Humira lost its record for peak annual drug sales, not to Keytruda as […]
